Banzel, Inovelon(rufinamide)
Banzel, Inovelon (rufinamide) is a small molecule pharmaceutical. Rufinamide was first approved as Inovelon on 2007-01-16. It is used to treat seizures in the USA. It has been approved in Europe to treat epilepsy.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
Banzel (generic drugs available since 2016-05-16)
Drug Products
FDA
EMA
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
banzel | New Drug Application | 2021-12-23 |
rufinamide | ANDA | 2023-03-20 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
seizures | HP_0007359 | D012640 | G40.4 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
11 clinical trials
View more details
![](https://www.pharmakb.com/hubfs/raw_assets/public/ccd-theme/images/generated-html-images/trials-plot.png)
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pain | D010146 | EFO_0003843 | R52 | — | 1 | — | — | — | 1 |
Peripheral nerve injuries | D059348 | — | 1 | — | — | — | 1 |
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | RUFINAMIDE |
INN | rufinamide |
Description | Rufinamide is a heteroarene and an aromatic amide. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | NC(=O)c1cn(Cc2c(F)cccc2F)nn1 |
Identifiers
PDB | — |
CAS-ID | 106308-44-5 |
RxCUI | 69036 |
ChEMBL ID | CHEMBL1201754 |
ChEBI ID | — |
PubChem CID | 129228 |
DrugBank | DB06201 |
UNII ID | WFW942PR79 (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
![](https://www.pharmakb.com/hubfs/raw_assets/public/ccd-theme/images/generated-html-images/top-terms-plot.png)
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 927 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
![](https://www.pharmakb.com/hubfs/raw_assets/public/ccd-theme/images/generated-html-images/top-adverse-reactions-plot.png)
Mock data
Subscribe for the real data
Subscribe for the real data
6,530 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more